Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN1190418C details a streamlined synthesis for high-purity distamycin derivatives, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN116179612A reveals multienzyme coupling for VD3. Enhances purity and load capacity while reducing chemical residues for supply chain stability.
Patent CN110684025A reveals a novel 2-step tadalafil synthesis avoiding toxic reagents. Achieves 90% yield for cost reduction in API manufacturing and supply chain stability.
Patent CN1894224A reveals a superior ethanol-based resolution process for Nefopam, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Novel dehydration-halogenation-hydrogenation route for beta-thymidine. Reduces corrosion, improves yield >85%, ensures HPLC >99.8% purity for reliable supply.
Patent CN102382780A reveals a novel Microbacterium oxydans strain for high-purity chiral alcohol production, offering significant cost reduction and supply chain stability for global API manufacturers.
Novel low-temperature bromination method for azide-salicylic acid. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN108546698A reveals high-activity aspartase mutant for L-aspartic acid. Enables cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel one-step synthesis of Sugammadex Sodium via triflic acid catalysis offers superior purity and cost efficiency for global pharmaceutical supply chains.
Novel synthetic route for 4-substituted piperidine derivatives offering reduced steps and high yield for pharmaceutical intermediate manufacturing.
Patent CN120624390A enables high-purity chiral amine synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel synthetic route for Pitavastatin Calcium intermediate offers high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN114437233B enables high-purity polypeptide dimer synthesis. Enhance supply chain reliability and reduce manufacturing costs with advanced stepwise oxidation technology.
Novel decarboxylation condensation and asymmetric reduction method enhances purity and reduces costs for sitagliptin manufacturing supply chains.
Patent CN113461555A introduces a streamlined Suzuki route for Terbutaline, eliminating hazardous hydrogenation and reducing steps for cost-effective API manufacturing.
Patent CN114394939A reveals a green 3-step route for cimetidine with >90% yield. Discover cost reduction in pharmaceutical manufacturing and high-purity supply solutions.
Patent CN105601630A reveals high-yield Vilsmeier route for diazepine intermediates. Achieve cost reduction and supply chain reliability with scalable manufacturing.
Novel synthesis of (R)-4-propyl dihydrofuran-2-one via Meldrum's acid. High optical purity, scalable route for Brivaracetam intermediates. Cost-effective manufacturing solution.
Advanced preparation method of Ivermectin utilizing Avermectin B2. Enhances yield to 72% while eliminating toxic tributyltin reagents for cost-effective manufacturing.
Patent CN113683650B reveals efficient synthesis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.